Ozempic semaglutide injection

Ozempic is a globally recognized prescription medication used for the treatment of type 2 diabetes and, increasingly, for weight management. The brand was developed by Novo Nordisk, a Danish multinational pharmaceutical company founded in 1923. Known for its innovation in diabetes care, Novo Nordisk continues to be the ultimate owner and primary manufacturer of the drug.

While the headquarters and chief manufacturing facilities are located in Bagsværd, Denmark, the massive global demand for semaglutide (the active ingredient in Ozempic) has led to production expansion across several countries, including specialized facilities in France, Brazil, and the United States. In Spain and other international markets, it is distributed through local subsidiaries of Novo Nordisk.